Neonatal Systemic Thrombosis: An Updated Overview.

Gea Oliveri Conti, Angelo Claudio Molinari, Salvatore Santo Signorelli, Martino Ruggieri, Alfina Grasso, Margherita Ferrante

Journal: Current vascular pharmacology 2019;16(5):499-509

PMID: 29345589

Abstract

Thromboembolic disease is a complex disorder with a multifactorial aetiology and a severe outcome. In newborns and children it may be missed or diagnosed late, thus worsening the prognosis. The neonatal disease is different from the disorder affecting older children and adults. However, scant epidemiological data and few randomised clinical trials regarding paediatric patients are available, and treatment recommendations are largely based on adult guidelines. Younger patients then have several decades over which they will suffer from the complications of thrombosis and risk of a new thrombotic episode. Current knowledge about neonatal thromboembolic disease and its prevention is reviewed here along with maternal, foetal, neonatal, pharmacological, environmental, lifestyle and occupational contributing factors. Additional data are urgently needed to improve diagnostic and therapeutic strategies and patient outcomes.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Environmental and Food Hygiene Laboratories (LIAA), Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia" , University of Catania, Catania, Italy.; Thrombosis and Haemostasis Unit, Giannina Gaslini Children`s Hospital, Genova, Italy.; Department of Clinical and Experimental Medicine, Catania University, Catania, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.